Fifth Third Bancorp
RXRX icon

Fifth Third Bancorp’s Recursion Pharmaceuticals RXRX Stock Holding History

Fifth Third Bancorp’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.7K Buy
4,540
+2,270
+100% +$7.56K ﹤0.01% 3599
2026
Q1 		$6.97K Buy
+2,270
New +$8.77K ﹤0.01% 3779
2025
Q2 		– Sell
-146
Closed -$772 – 2632
2025
Q1 		$772 Buy
+146
New +$1.06K ﹤0.01% 2422

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fifth Third Bancorp's RXRX Position: Q2 2026 in Review

Fifth Third Bancorp increased its Recursion Pharmaceuticals (RXRX) stake by 100% in Q2 2026, buying an estimated $7.56K and bringing the position to 4,540 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3599.

Fifth Third Bancorp first reported a position in RXRX in Q1 2025 and has held it in 3 quarters since. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Fifth Third Bancorp held 4,540 shares of Recursion Pharmaceuticals worth $16.7K as of Q2 2026.
  • Fifth Third Bancorp bought 2,270 Recursion Pharmaceuticals shares in Q2 2026, an estimated $7.56K.
  • Recursion Pharmaceuticals made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3599 holding.
  • Fifth Third Bancorp first reported a position in Recursion Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.